Bristol Myers Squibb results top estimates as new drugs post strong sales growth

Bristol Myers Squibb also issued its full-year 2024 forecast, which was generally in line with expectations.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.